FindTrial
Sign In

Comparison of anesthetic agents to evaluate pulse blood pressure changes and recovery in ear surgery

A randomized comparative study of Desflurane and Sevoflurane with Esmolol to evaluate haemodynamic parameters and recovery characteristics in middle ear surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027800
Enrollment
100
Registered
2020-09-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H60-H95- Diseases of the ear and mastoid process

Interventions

Intervention1: Through endotracheal intubation, inhalation agent sevoflurane or desflurane and intravenous inj. esmolol: After endotracheal intubation inhalation agent sevoflurane 1 to 3 percentage or

Sponsors

Government Of Gujarat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I or II, Middle ear surgery

Exclusion criteria

Exclusion criteria: Patient refusal, ASA grade III to V, Pregnancy or lactating mothers, History of hepatic, renal or cardiopulmonary diseases, History of significant neurological, psychiatric, or neuromuscular disorders, Alcoholism, diabetes, hyper or hypothyroidism, Patients on calcium channel blockers, Bleeding diathesis

Design outcomes

Primary

MeasureTime frame
Changes in Perioperative haemodynamic parametersTimepoint: Time period will be preoperative from recording basal vitals to postoperative five minutes after extubation—

Secondary

MeasureTime frame
visibility of the surgical field, surgeonâ??s satisfaction, postoperative recovery profile and perioperative complicationsTimepoint: start of surgery to one hour postoperative period—

Countries

India

Contacts

Public ContactDR Smita R Engineer

B J Medical College Civil Hospital

seng_90@yahoo.com9825504948

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026